Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Weekly Wrap 20 March

Bell Direct
March 20, 2020

Market Update 20 March

Jessica Amir
March 20, 2020

Market Update 19 March

Jessica Amir
March 19, 2020

Morning Bell 18 March

Jessica Amir
March 18, 2020

Morning Bell 17 March

Jessica Amir
March 17, 2020

Market Update 16 March

Bell Direct
March 16, 2020

Weekly Wrap 13 March

Jessica Amir
March 13, 2020

Market Update 12 March

Paulina Peters
March 12, 2020

Morning Bell 11 March

Jessica Amir
March 11, 2020

ETF mini-series 3/3: Top ETF picks

Jessica Amir
March 10, 2020